Arthur S Hong1,2,3, Danh Q Nguyen4, Simon Craddock Lee2,3, D Mark Courtney5, John W Sweetenham1,3, Navid Sadeghi1,3,6, John V Cox1,3,6, Hannah Fullington2, Ethan A Halm1,2,3. 1. Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX. 2. Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX. 3. Harold C. Simmons Comprehensive Cancer Center, Dallas, TX. 4. University of Texas Southwestern Medical School, Dallas, TX. 5. Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, TX. 6. Parkland Health & Hospital System, Dallas, TX.
Abstract
PURPOSE: To determine whether emergency department (ED) visit history prior to cancer diagnosis is associated with ED visit volume after cancer diagnosis. METHODS: This was a retrospective cohort study of adults (≥ 18 years) with an incident cancer diagnosis (excluding nonmelanoma skin cancers or leukemia) at an academic medical center between 2008 and 2018 and a safety-net hospital between 2012 and 2016. Our primary outcome was the number of ED visits in the first 6 months after cancer diagnosis, modeled using a multivariable negative binomial regression accounting for ED visit history in the 6-12 months preceding cancer diagnosis, electronic health record proxy social determinants of health, and clinical cancer-related characteristics. RESULTS: Among 35,090 patients with cancer (49% female and 50% non-White), 57% had ≥ 1 ED visit in the 6 months immediately following cancer diagnosis and 20% had ≥ 1 ED visit in the 6-12 months prior to cancer diagnosis. The strongest predictor of postdiagnosis ED visits was frequent (≥ 4) prediagnosis ED visits (adjusted incidence rate ratio [aIRR]: 3.68; 95% CI, 3.36 to 4.02). Other covariates associated with greater postdiagnosis ED use included having 1-3 prediagnosis ED visits (aIRR: 1.32; 95% CI, 1.28 to 1.36), Hispanic (aIRR: 1.12; 95% CI, 1.07 to 1.17) and Black (aIRR: 1.21; 95% CI, 1.17 to 1.25) race, homelessness (aIRR: 1.95; 95% CI, 1.73 to 2.20), advanced-stage cancer (aIRR: 1.30; 95% CI, 1.26 to 1.35), and treatment regimens including chemotherapy (aIRR: 1.44; 95% CI, 1.40 to 1.48). CONCLUSION: The strongest independent predictor for ED use after a new cancer diagnosis was frequent ED visits before cancer diagnosis. Efforts to reduce potentially avoidable ED visits among patients with cancer should consider educational initiatives that target heavy prior ED users and offer them alternative ways to seek urgent medical care.
PURPOSE: To determine whether emergency department (ED) visit history prior to cancer diagnosis is associated with ED visit volume after cancer diagnosis. METHODS: This was a retrospective cohort study of adults (≥ 18 years) with an incident cancer diagnosis (excluding nonmelanoma skin cancers or leukemia) at an academic medical center between 2008 and 2018 and a safety-net hospital between 2012 and 2016. Our primary outcome was the number of ED visits in the first 6 months after cancer diagnosis, modeled using a multivariable negative binomial regression accounting for ED visit history in the 6-12 months preceding cancer diagnosis, electronic health record proxy social determinants of health, and clinical cancer-related characteristics. RESULTS: Among 35,090 patients with cancer (49% female and 50% non-White), 57% had ≥ 1 ED visit in the 6 months immediately following cancer diagnosis and 20% had ≥ 1 ED visit in the 6-12 months prior to cancer diagnosis. The strongest predictor of postdiagnosis ED visits was frequent (≥ 4) prediagnosis ED visits (adjusted incidence rate ratio [aIRR]: 3.68; 95% CI, 3.36 to 4.02). Other covariates associated with greater postdiagnosis ED use included having 1-3 prediagnosis ED visits (aIRR: 1.32; 95% CI, 1.28 to 1.36), Hispanic (aIRR: 1.12; 95% CI, 1.07 to 1.17) and Black (aIRR: 1.21; 95% CI, 1.17 to 1.25) race, homelessness (aIRR: 1.95; 95% CI, 1.73 to 2.20), advanced-stage cancer (aIRR: 1.30; 95% CI, 1.26 to 1.35), and treatment regimens including chemotherapy (aIRR: 1.44; 95% CI, 1.40 to 1.48). CONCLUSION: The strongest independent predictor for ED use after a new cancer diagnosis was frequent ED visits before cancer diagnosis. Efforts to reduce potentially avoidable ED visits among patients with cancer should consider educational initiatives that target heavy prior ED users and offer them alternative ways to seek urgent medical care.
Authors: Ruben Amarasingham; Billy J Moore; Ying P Tabak; Mark H Drazner; Christopher A Clark; Song Zhang; W Gary Reed; Timothy S Swanson; Ying Ma; Ethan A Halm Journal: Med Care Date: 2010-11 Impact factor: 2.983
Authors: Gabriel A Brooks; Hajime Uno; Erin J Aiello Bowles; Alexander R Menter; Maureen O'Keeffe-Rosetti; Anna N A Tosteson; Debra P Ritzwoller; Deborah Schrag Journal: JCO Clin Cancer Inform Date: 2019-04
Authors: Joanna-Grace M Manzano; Ruili Luo; Linda S Elting; Marina George; Maria E Suarez-Almazor Journal: J Clin Oncol Date: 2014-10-06 Impact factor: 44.544
Authors: Scott D Ramsey; Aasthaa Bansal; Catherine R Fedorenko; David K Blough; Karen A Overstreet; Veena Shankaran; Polly Newcomb Journal: J Clin Oncol Date: 2016-01-25 Impact factor: 44.544
Authors: Jane W Njeru; Jennifer L St Sauver; Debra J Jacobson; Jon O Ebbert; Paul Y Takahashi; Chun Fan; Mark L Wieland Journal: BMC Health Serv Res Date: 2015-05-29 Impact factor: 2.655
Authors: Rebecca S Lash; Janice F Bell; Richard J Bold; Jill G Joseph; Rosemary D Cress; Ted Wun; Ann M Brunson; Patrick S Romano Journal: J Community Support Oncol Date: 2017 Mar-Apr